SHUKRA PHARMACEUTICALS
Back to Cashflow Statement
|
SHUKRA PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-4.52 Cr | ₹12 Cr | ₹4.94 Cr | ₹-6.68 Cr | ₹1.74 Cr |
What is the latest Cash Flow from Financing Activities ratio of SHUKRA PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-4.52 Cr |
| Mar2024 | ₹12 Cr |
| Mar2023 | ₹4.94 Cr |
| Mar2022 | ₹-6.68 Cr |
| Mar2021 | ₹1.74 Cr |
How is Cash Flow from Financing Activities of SHUKRA PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-4.52 Cr | Negative | |
| Mar2024 | ₹12 Cr | 151.06 | |
| Mar2023 | ₹4.94 Cr | Positive | |
| Mar2022 | ₹-6.68 Cr | Negative | |
| Mar2021 | ₹1.74 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹1,326.7 Cr | -4.8% | 2.5% | 56% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | -4.8% |
2.5% |
56% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses